Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRLX101 in advanced solid tumors
NCT00333502Phase 2Completed
- Sponsor
- Lumos Pharma, Inc.
- Start
- May 2006
- Primary completion
- Nov 2011
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of CRLX101 in solid tumor, sponsored by Lumos Pharma, Inc.. Started May 2006; status: completed.
02
Drugs
CRLX101
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00333502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333502.